Accelerating development from clinical concept to patient impact through expert clinical research consulting and innovative trial design.
Science-driven. Client-focused. Patient-centered clinical trials.
Synergy Clinical Research Consulting is an independent clinical development consultancy specializing in rare and ultra-rare disease trials. Founded by Debra Lounsbury, a clinical scientist with 20+ years in biopharmaceutical drug development, Synergy provides trial design, medical monitoring, and DMC/SMC leadership for sponsors from early phase through Phase 3.
Known for executing complex programs with rigor and momentum—and for the trusted relationships with sponsors, investigators, KOLs, and patient advocacy groups that move trials forward.
At Synergy Clinical Research Consulting, we deliver expert clinical research consulting and strategic trial leadership that support high-quality, end-to-end clinical trial development—from protocol design through execution and analysis. Our approach integrates robust clinical trial data strategy, seamless collaboration, and scientific rigor to generate trustworthy, decision-enabling evidence that advances innovative therapies for patients with unmet medical needs, including those in rare disease research.
We are your trusted clinical trial consultant, providing expertise in protocol development, KOL and advocacy engagement, participant recruitment and retention, and advanced statistical analysis. We partner with you to deliver patient-centered clinical trials through collaborative clinical trial design and key stakeholder engagement, ensuring every step supports patients and their caregivers, and produces meaningful, decision-enabling evidence.
Together, sharing the goal of advancing science and impacting lives.
What We Do
We offer a wide array of clinical development consulting services including:
Clinical Oversight & Quality Leadership
- Global Medical Monitoring
- Independent Data Monitoring Committees
- Quality & Risk-Based Oversight
- Quality Metrics & Data Review
- Inspection Readiness
Clinical Strategy, Evidence Generation & Program Execution
- Strategic Clinical Development
- Evidence Generation & Data Insight
- Operational Program Execution
- Patient-Centered Enrollment & Retention
Clinical Data Strategy & Analytics
- Advanced Statistical Design & Analysis
- Risk-Based & Real-Time Data Monitoring
- Strategic Data Access & Governance
- Emerging AI-Driven Insights
Extensive Experience in Clinical Development Across Disease States
Experience spans rare and ultra-rare disease—including phenylketonuria (PKU), Pompe disease, MPS IVA, Lambert-Eaton myasthenic syndrome, and vascular Ehlers-Danlos syndrome—as well as oncology, pulmonary fibrosis, sepsis, and pain.
in clinical development
deep specialization in rare and ultra-rare disease
contributed to globally approved rare disease treatments
across rare disease, oncology, and critical care
early phase through pivotal trials
Partners In Success Here’s what a few of our clients have to say about working with Synergy
Ann & Robert H. Lurie Children’s Hospital of Chicago
England and Wales registered Charity
Oregon Health & Science University, Portland OR
Ultragenyx
Executive Director Statistical Science
National PKU Alliance
